(Q53494635)

14 May 2018

title

Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders. (English)

1 reference

14 May 2018

author

Angela Dispenzieri

4

1 reference

14 May 2018

David Dingli

2

David Dingli

1 reference

14 May 2018

3

Martha Q Lacy

1 reference

14 May 2018

7

S Vincent Rajkumar

1 reference

14 May 2018

Morie A Gertz

9

Morie A Gertz

1 reference

14 May 2018

Suzanne R Hayman

5

Suzanne R Hayman

1 reference

14 May 2018

Mark R Litzow

8

Mark R Litzow

1 reference

14 May 2018

Francis K Buadi

6

Francis K Buadi

1 reference

14 May 2018

Shaji K Kumar

1

Shaji K Kumar

1 reference

14 May 2018

language of work or name

English

0 references

publication date

3 March 2008

1 reference

14 May 2018

British Journal of Haematology

published in

1 reference

14 May 2018

volume

141

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

205-211

1 reference

14 May 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Immunoglobulin free light chains and solitary plasmacytoma of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Genetics and cytogenetics of multiple myeloma: a workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Prognostic factors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Smoldering multiple myeloma: natural history and recognition of an evolving type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07069.X

10.1111/J.1365-2141.2008.07069.X

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018